Search Results for: cannabinoid

Skipta And The Fresh Toast Bring Cannabinoid Medicine Information To Healthcare Professionals

Skipta and The Fresh Toast

PENNSYLVANIA & WASHINGTON: Skipta, a leading social network of specialized online medical communities for verified healthcare professionals, including Oncology Nation, Psychiatrist Connect and Doctor Unite, announced today its partnership with new media company, The Fresh Toast, to provide trusted, reliable information on cannabinoid medicine. In a first for the cannabis industry, this partnership will provide guidelines and research information Read the full article…

Veterinary Cannabinoid Therapeutics Takes Center Stage At Cannabis in Veterinary Medicine Symposium

Do people really want a medical marijuana program for their pets?

A panel of seven Colorado doctors discuss using cannabis with animals COLORADO: Roughly 3-5% of all dogs have genetic epilepsy, and 14 million dogs have some form of arthritis. CBD oil is helping millions of people around the world, and as a result the veterinary medical market is becoming more aware of the relief CBD can Read the full article…

Nanoparticle Drones To Target Lung Cancer with Radiosensitizers And Cannabinoids

nanotechnology

Wilfred Ngwa1,2*, Rajiv Kumar1,3, Michele Moreau1,2, Raymond Dabney4 and Allen Herman4 1Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, United States 2University of Massachusetts Lowell, Lowell, MA, United States 3Northeastern University, Boston, MA, United States 4Cannabis Science Inc., Irvine, CA, United States   CALIFORNIA: Nanotechnology has opened up a new, previously unimaginable Read the full article…

International Collaborative Study Reveals The Neuroprotective Properties of Phytocannabinoid Δ9-THCA

A recent Δ9-THCA (Δ9-tetrahydrocannabinol acid) study, initiated by three leading companies active in the field of medicinal cannabis research, has demonstrated its ability as a promising treatment modality for Huntington's disease (HD) and other metabolic, neurodegenerative and neuroinflammatory diseases.

SPAIN:  Advanced medical research conducted at Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC) as a collaborative effort between Phytoplant Research SL, VivaCell Biotechnology España SL, and Emerald Health Pharmaceuticals has unveiled the potent neuroprotective ability of Δ9-THCA, a phytocannabinoid produced in Cannabis sativa L. The research paper was accepted and published in the British Journal of Pharmacology. Read the full article…

Case Reports: Cannabinoids Improve Speech In Patients With Tourette Syndrome

Cannabinoids Improve Speech In Patients With Tourette Syndrome

GERMANY: The daily administration of cannabinoids is associated with improved speech fluency in patients with Tourette Syndrome (TS), according to a pair of case reports published in The International Journal of Molecular Sciences. A pair of researchers from the Hannover Medical School in Germany assessed the impact of daily cannabinoid treatment in two TS patients with treatment-resistant vocal Read the full article…

Intec Pharma Reports Clinical Results From Phase I Trial of Accordion Pill For Cannabinoid Therapies

Intec Pharma Reports Clinical Results From Phase I Trial of Accordion Pill for Cannabinoid Therapies

ISRAEL: Intec Pharma, a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology, announced the results from a Phase I clinical trial of AP-CBD/THC, its Accordion Pill platform with cannabidiol (CBD) and tetrahydrocannabinol (THC), the two primary cannabinoids contained in Cannabis sativa. “We’re excited about these encouraging results from our Read the full article…

OWC Pharmaceutical To Begin Testing On Cannabinoid-Infused Psoriasis Cream

Cannabis-infused Psoriasis cream

ISRAEL: OWC Pharmaceutical Research Corp., an Israeli-based developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, announced it has received Institutional Review Board (IRB) approval to conduct safety testing on its proprietary topical crème compound for the treatment of psoriasis and related skin conditions. The approval follows the Company’s February 1, 2017 8K filing Read the full article…

New Study Explores The Diversity of Phytocannabinoids of Different Botanical Origin

phytocannabinoids

An international team of leading researchers have paved the way to exploring the biomedical potential of phytocannabinoids, going beyond the THC structural motif and their occurrence in cannabis. SPAIN: In the first ever attempt to include phytocannabinoids from additional natural sources apart from those derived from C. sativa, the Hebrew University in Jerusalem, the University of Córdoba, Read the full article…

Librede Awarded NIH Funding to Optimize Cannabinoid Production in Yeast

cbd

CALIFORNIA: Librede, a San Diego-based synthetic biology company, has received a Phase I Small Business Innovative Research (SBIR) Grant from the National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health (NIH), to improve Cannabidiol production in genetically engineered yeast. Cannabidiol (CBD) is one of several pharmacologically active chemicals (cannabinoids) found in Read the full article…

Company Patents Cannabinoid-Releasing Chewing Gum

AXIM Biotechnologies recently acquired intellectual rights for a U.S. patent for time-release cannabidiol chewing gum.

DISTRICT OF COLUMBIA:  It’s a perfect storm situation for AXIM Biotechnologies. July 9, The FDA announced serious warnings for NSAIDs anti-inflammatory drugs- drugs which AXIM say their medicated gum can replace. AXIM  recently acquired intellectual rights for a U.S. patent for time-release cannabidiol chewing gum. CanChew Biotechnologies will hold the patent for production with a 50 year licensing agreement with AXIM. Read the full article…